Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

78.08

-1.72 (-2.16%)

At close: Aug 28, 2026, 4:00 PM EDT

79.63

+1.55 (1.99%)

After-hours: Aug 28, 2026, 7:49 PM EDT

KNSA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,092	3,127	1,428	1,234	1,042	811
Market Cap Growth	143.94%	118.92%	15.76%	18.45%	28.46%	-32.59%
Enterprise Value	5,575	2,784	1,215	1,046	848	617
Last Close Price	78.08	41.25	19.78	17.54	14.98	11.77

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	78.85	52.99	-	87.60	5.68	-
Forward PE	54.89	27.32	42.93	170.84	170.84	-
PS Ratio	7.25	4.61	3.37	4.57	4.73	21.04
PB Ratio	9.31	5.51	3.26	2.81	2.63	4.38
P/TBV Ratio	9.53	5.66	3.38	2.93	2.76	4.89
P/FCF Ratio	33.32	22.92	56.20	93.67	182.67	-
P/OCF Ratio	32.94	22.66	55.59	92.76	179.37	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.63	4.11	2.87	3.87	3.85	16.02
EV/EBITDA Ratio	54.64	35.34	-	-	69.62	-
EV/EBIT Ratio	55.61	36.06	-	-	86.73	-
EV/FCF Ratio	30.49	20.41	47.81	79.39	148.64	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.02	0.02	0.03	0.02	0.03
Debt / EBITDA Ratio	0.08	0.11	-	-	0.38	-
Debt / FCF Ratio	0.05	0.07	0.39	0.93	1.04	-
Net Debt / Equity Ratio	-0.79	-0.71	-0.53	-0.44	-0.47	-0.95
Net Debt / EBITDA Ratio	-5.07	-5.14	5.32	8.49	-15.17	1.14
Net Debt / FCF Ratio	-2.83	-2.97	-9.20	-14.74	-32.39	1.39
Asset Turnover	1.08	1.01	0.77	0.55	0.64	0.13
Inventory Turnover	6.42	7.56	6.58	3.41	3.72	-
Quick Ratio	3.21	3.09	2.84	3.58	4.48	4.15
Current Ratio	3.90	3.79	3.30	4.34	5.16	4.38
Return on Equity (ROE)	14.04%	11.73%	-9.85%	3.37%	63.10%	-63.55%
Return on Assets (ROA)	8.05%	7.18%	-5.15%	-3.19%	1.76%	-33.63%
Return on Invested Capital (ROIC)	49.89%	27.89%	-20.30%	-11.05%	8.87%	-7244.96%
Return on Capital Employed (ROCE)	13.80%	12.40%	-9.50%	-5.40%	2.40%	-83.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.32%	1.89%	-3.02%	1.14%	17.60%	-19.48%
FCF Yield	3.00%	4.36%	1.78%	1.07%	0.55%	-15.63%
Buyback Yield / Dilution	-9.97%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%

SEC Filings: 10-K · 10-Q